There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
The benefit of adjuvant therapy (AT) for biliary tract cancer (BTC) is unclear, with
conflicting results from nonrandomized studies. We report a systematic review and
meta-analysis to determine the impact of AT on survival.